首页> 美国卫生研究院文献>Rambam Maimonides Medical Journal >Cannabis One Health and Veterinary Medicine: Cannabinoids’ Role in Public Health Food Safety and Translational Medicine
【2h】

Cannabis One Health and Veterinary Medicine: Cannabinoids’ Role in Public Health Food Safety and Translational Medicine

机译:大麻一种健康和兽医学:大麻素在公共卫生食品安全和转化医学中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Public health is connected to cannabis with regard to food, animal feed (feed), and pharmaceuticals. Therefore, the use of phytocannabinoids should be examined from a One Health perspective. Current knowledge on medical cannabis treatment (MCT) does not address sufficiently diseases which are of epidemiological and of zoonotic concern. The use of cannabinoids in veterinary medicine is illegal in most countries, mostly due to lack of evidence-based medicine. To answer the growing need of scientific evidence-based applicable medicine in both human and veterinary medicine, a new approach for the investigation of the therapeutic potential of cannabinoids must be adopted. A model that offers direct study of a specific disease in human and veterinary patients may facilitate development of novel therapies. Therefore, we urge the regulatory authorities—the ministries of health and agriculture (in Israel and worldwide)—to publish guidelines for veterinary use due to its importance to public health, as well as to promote One Health-related preclinical translational medicine studies for the general public health.
机译:在食品,动物饲料(饲料)和药品方面,公共卫生与大麻有关。因此,应从“一个健康”的角度检查植物大麻素的使用。目前有关医用大麻治疗(MCT)的知识未能充分解决流行病学和人畜共患病问题。在大多数国家/地区,在兽药中使用大麻素是违法的,这主要是由于缺乏循证医学。为了满足对人类和兽医学中基于科学证据的适用医学日益增长的需求,必须采用一种研究大麻素治疗潜力的新方法。提供直接研究人类和兽医患者中特定疾病的模型可能有助于开发新疗法。因此,我们敦促监管机构-以色列和全世界的卫生与农业部-由于其对公共卫生的重要性而发布兽药使用指南,并促进与One Health相关的临床前转化医学研究。一般公共卫生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号